메뉴 건너뛰기




Volumn 21, Issue 9, 2006, Pages 2352-2353

Progression of renal disease - Can we forget about inhibition of the renin-angiotensin system? Authors' reply

Author keywords

ACE inhibitors; Angiotensin receptor antagonists; Antihypertensive drugs; Clinical trials; End stage renal disease

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO;

EID: 33750443932     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl316     Document Type: Editorial
Times cited : (1)

References (7)
  • 1
    • 33645000740 scopus 로고    scopus 로고
    • Renoprotective effects of renin-angiotensin-system inhibitors: Authors reply
    • Casas JP, Vallance P, Smeeth L, Hingorani AD, MacAllister RJ. Renoprotective effects of renin-angiotensin-system inhibitors: Authors reply. Lancet 2006; 367: 900-902
    • (2006) Lancet , vol.367 , pp. 900-902
    • Casas, J.P.1    Vallance, P.2    Smeeth, L.3    Hingorani, A.D.4    MacAllister, R.J.5
  • 2
    • 28844504752 scopus 로고    scopus 로고
    • Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: Systematic review and meta-analysis
    • Casas JP, Chua W, Loukogeorgakis S et al. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: Systematic review and meta-analysis. Lancet 2005; 366: 2026-2033
    • (2005) Lancet , vol.366 , pp. 2026-2033
    • Casas, J.P.1    Chua, W.2    Loukogeorgakis, S.3
  • 3
    • 33750474387 scopus 로고    scopus 로고
    • ACE inhibitors and progression of non-diabetic renal disease: A meta-analysis of patient-level data
    • Jafar TH, Schmid CH, Landa M et al. ACE inhibitors and progression of non-diabetic renal disease: A meta-analysis of patient-level data. Ann Int Med 2001; 135: 78-87
    • (2001) Ann Int Med , vol.135 , pp. 78-87
    • Jafar, T.H.1    Schmid, C.H.2    Landa, M.3
  • 4
    • 33644809993 scopus 로고    scopus 로고
    • Antihypertensive agents for primary prevention of diabetic nephropathy
    • Strippoli GF, Craig M, Schena FP, Craig JC. Antihypertensive agents for primary prevention of diabetic nephropathy. J Am Soc Nephrol 2005; 16: 3081-3091
    • (2005) J Am Soc Nephrol , vol.16 , pp. 3081-3091
    • Strippoli, G.F.1    Craig, M.2    Schena, F.P.3    Craig, J.C.4
  • 5
    • 33645011106 scopus 로고    scopus 로고
    • Progression of kidney disease: The role of blood pressure control, proteinuria, and ACE inhibition: A patient-level metaanalysis
    • Jafar TH, Stark PC, Schmid CH et al. Progression of kidney disease: The role of blood pressure control, proteinuria, and ACE inhibition: A patient-level metaanalysis. Ann Int Med 2003; 135: 73-87
    • (2003) Ann Int Med , vol.135 , pp. 73-87
    • Jafar, T.H.1    Stark, P.C.2    Schmid, C.H.3
  • 6
    • 0029918188 scopus 로고    scopus 로고
    • Rationale and design for the Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial (ALLHAT)
    • ALLHAT Research Group
    • Davis BR, Cutler JA, Gordon DJ et al. Rationale and design for the Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. Am J Hypertens 1996; 9: 342-360
    • (1996) Am J Hypertens , vol.9 , pp. 342-360
    • Davis, B.R.1    Cutler, J.A.2    Gordon, D.J.3
  • 7
    • 0030742003 scopus 로고    scopus 로고
    • The promise and problems of meta-analysis
    • Bailar JC, 3rd. The promise and problems of meta-analysis. N Engl J Med 1997; 337: 559-561
    • (1997) N Engl J Med , vol.337 , pp. 559-561
    • Bailar III, J.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.